• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚硫酸戊聚糖作为草酸钙晶体生长的抑制剂

Pentosan polysulfate as an inhibitor of calcium oxalate crystal growth.

作者信息

Martin X, Werness P G, Bergert J H, Smith L H

出版信息

J Urol. 1984 Oct;132(4):786-8. doi: 10.1016/s0022-5347(17)49873-9.

DOI:10.1016/s0022-5347(17)49873-9
PMID:6206244
Abstract

Pentosan polysulfate was studied as a calcium oxalate crystal growth inhibitor. The inhibition from pentosan polysulfate at concentrations ranging from 3.5 to 110 mg./l. was measured in simple inorganic calcium oxalate solutions at pH 5, 6 and 7. Pentosan polysulfate also was mixed with urine at concentrations from 10 to 350 mg./l. and inhibition determined. Measurement of calcium oxalate crystal growth inhibition was performed in a seeded crystal growth system. One inhibitory unit (concentration of pentosan polysulfate necessary to give a 50 per cent reduction in the rate of crystal growth) was 5.7 +/- 2 mg./l. at pH 5, 7.2 +/- 1.1 mg./l. at pH 6 and 6.0 +/- 2.1 mg./l. at pH 7. Urine-pentosan polysulfate mixtures showed more inhibitory activity than the predicted inhibition present. Addition of pentosan polysulfate to urine at a concentration of 10 mg./l. increased the inhibitory activity from 45 +/- 3 to 59 +/- 3 IU/l. Pentosan polysulfate is a potent calcium oxalate crystal growth inhibitor in urine at physiologic pH levels. If the urinary concentration of pentosan polysulfate after oral administration reaches 10 mg./l., the increase in inhibitory activity in urine that may occur might be important in the treatment of patients who form calcium oxalate calculi within the urinary tract.

摘要

对戊聚糖多硫酸盐作为草酸钙晶体生长抑制剂进行了研究。在pH值为5、6和7的简单无机草酸钙溶液中,测定了浓度范围为3.5至110毫克/升的戊聚糖多硫酸盐的抑制作用。戊聚糖多硫酸盐还以10至350毫克/升的浓度与尿液混合,并测定其抑制作用。在接种晶体生长系统中进行草酸钙晶体生长抑制的测量。一个抑制单位(使晶体生长速率降低50%所需的戊聚糖多硫酸盐浓度)在pH值为5时为5.7±2毫克/升,在pH值为6时为7.2±1.1毫克/升,在pH值为7时为6.0±2.1毫克/升。尿液-戊聚糖多硫酸盐混合物显示出比预测的抑制作用更强的抑制活性。以10毫克/升的浓度向尿液中添加戊聚糖多硫酸盐,可使抑制活性从45±3国际单位/升增加到59±3国际单位/升。在生理pH水平下,戊聚糖多硫酸盐是尿液中一种有效的草酸钙晶体生长抑制剂。如果口服后尿液中戊聚糖多硫酸盐的浓度达到10毫克/升,尿液中可能出现的抑制活性增加对于治疗尿路中形成草酸钙结石的患者可能具有重要意义。

相似文献

1
Pentosan polysulfate as an inhibitor of calcium oxalate crystal growth.聚硫酸戊聚糖作为草酸钙晶体生长的抑制剂
J Urol. 1984 Oct;132(4):786-8. doi: 10.1016/s0022-5347(17)49873-9.
2
[Inhibitory effect of sodium pentosan polysulfate on the formation, growth and aggregation of calcium oxalate in vitro].戊聚糖多硫酸酯钠对草酸钙体外形成、生长及聚集的抑制作用
Nihon Hinyokika Gakkai Zasshi. 1989 Apr;80(4):526-31. doi: 10.5980/jpnjurol1989.80.526.
3
[Studies of sodium pentosan polysulphate (SPP) therapy on the urinary stone disease. Experimental studies on the calcium oxalate crystallization and the effects in healthy subjects].[戊聚糖多硫酸钠(SPP)治疗尿路结石病的研究。草酸钙结晶的实验研究及对健康受试者的影响]
Nihon Hinyokika Gakkai Zasshi. 1991 Feb;82(2):246-53. doi: 10.5980/jpnjurol1989.82.246.
4
[A study of crystallization on urolithiasis in vitro].[体外尿路结石结晶的研究]
Hinyokika Kiyo. 1991 Oct;37(10):1091-6.
5
Sodium pentosan polysulphate as a polyanionic inhibitor of calcium oxalate crystallization in vitro and in vivo.戊聚糖多硫酸酯钠作为草酸钙结晶的体外和体内多阴离子抑制剂。
Clin Sci (Lond). 1985 Mar;68(3):369-71. doi: 10.1042/cs0680369.
6
Influence of sodium pentosan polysulphate and certain inhibitors on calcium oxalate crystal growth.戊聚糖多硫酸酯钠及某些抑制剂对草酸钙晶体生长的影响。
Mol Cell Biochem. 1996 Mar 9;156(1):31-5. doi: 10.1007/BF00239316.
7
[The quantitative study of inhibitory effect of pentosan polysulfate and chlorophyllin on the experimental calcium oxalate stone].[聚戊糖硫酸酯和叶绿酸对实验性草酸钙结石抑制作用的定量研究]
Nihon Hinyokika Gakkai Zasshi. 1989 Jun;80(6):861-9. doi: 10.5980/jpnjurol1989.80.861.
8
Pentosan polysulfate, a sulfated oligosaccharide, is a potent and selective anti-HIV agent in vitro.戊聚糖多硫酸酯,一种硫酸化低聚糖,在体外是一种有效的选择性抗HIV药物。
Antiviral Res. 1988 Sep;9(6):335-43. doi: 10.1016/0166-3542(88)90035-6.
9
[The development of continuous crystallizer and observation of formation and growth of calcium oxalate crystals].[连续结晶器的研制及草酸钙晶体形成与生长的观察]
Hinyokika Kiyo. 1991 Jun;37(6):569-75.
10
Is there a role for pentosan polysulfate in the prevention of calcium oxalate stones?戊聚糖多硫酸盐在预防草酸钙结石方面有作用吗?
J Endourol. 2003 Dec;17(10):855-8. doi: 10.1089/089277903772036136.

引用本文的文献

1
Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.草酸钙结晶的尿中抑制剂及其在结石形成中的潜在作用。
World J Urol. 1997;15(3):155-64. doi: 10.1007/BF02201852.
2
Glycosaminoglycans, proteins, and stone formation: adult themes and child's play.糖胺聚糖、蛋白质与结石形成:成人话题与儿童游戏
Pediatr Nephrol. 1996 Oct;10(5):656-66. doi: 10.1007/s004670050185.
3
Host defense within the urinary tract. I. Bacterial adhesion initiates an uroepithelial defense mechanism.尿路中的宿主防御。I. 细菌黏附引发尿路上皮防御机制。
Pediatr Nephrol. 1996 Oct;10(5):568-72. doi: 10.1007/s004670050162.
4
Glycosaminoglycans and other sulphated polysaccharides in calculogenesis of urinary stones.糖胺聚糖及其他硫酸化多糖在尿路结石形成过程中的作用
World J Urol. 1994;12(1):43-8. doi: 10.1007/BF00182050.
5
Glycosaminoglycans, uric acid and calcium oxalate urolithiasis.糖胺聚糖、尿酸与草酸钙尿路结石
Urol Res. 1991;19(6):375-80. doi: 10.1007/BF00310153.